<DOC>
	<DOC>NCT01872286</DOC>
	<brief_summary>Capsule endoscopy has been shown to be the first-line endoscopic procedure for small bowel disease. This study was aimed to compare the performance between the frequency-altering AKE-1 capsule and the Pillcam SB2 in patients with suspected small bowel disease.</brief_summary>
	<brief_title>Comparison of the Frequency-altering AKE-1 Capsule and Pillcam SB2</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<criteria>obscure gastrointestinal bleeding chronic diarrhea suspected Crohn's disease chronic abdominal pain neoplastic lesions of small bowel patients with any contraindication to capsule endoscopy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Capsule Endoscopy</keyword>
</DOC>